N4 Pharma Plc

DB:0GO Stock Report

Market Cap: €2.5m

N4 Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0GO?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,730,0530.438%
General Public81,622,47520.7%
Individual Insiders101,939,17625.8%
Institutions209,488,67553.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 46.9%.

Top Shareholders

Top 25 shareholders own 79.06% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
28.2%
Jarvis Securities plc, Asset Management Arm
111,162,920€703.7k207%0.06%
8.36%
Marc Mathenz
33,000,000€208.9k0%no data
8.36%
Mathenz Kay
33,000,000€208.9k0%no data
6.88%
HBOS Investment Fund Managers Limited
27,163,794€172.0k5.67%no data
5.91%
Peel Hunt LLP., Asset Management Arm
23,328,441€147.7k21,000%0.04%
5.8%
Barclays Bank PLC, Wealth and Investment Management Division
22,878,079€144.8k83.7%no data
4.77%
David Farrier
18,815,000€119.1k0%no data
4.3%
Nigel Theobald
16,981,319€107.5k0%no data
1.28%
IG Group Holdings Plc, Asset Management Arm
5,048,109€32.0k1.19%no data
1.09%
HSBC Global Asset Management (UK) Limited
4,316,051€27.3k9.63%no data
0.94%
Charles Stanley & Co. Ltd, Asset Management Arm
3,694,839€23.4k25.4%no data
0.51%
Close Asset Management Limited
2,013,395€12.7k832%no data
0.44%
Joh. Berenberg, Gossler & Co. KG, Asset Management Arm
1,739,034€11.0k0%no data
0.44%
Lloyds Banking Group plc
1,730,053€11.0k4.85%no data
0.43%
Nplus1 Singer Advisory LLP, Asset Management Arm
1,681,174€10.6k645%0.12%
0.26%
Fidelity International Ltd
1,015,316€6.4k0.08%no data
0.2%
Puma Investment Management Limited
791,181€5.0k2,080%no data
0.18%
UBS Asset Management AG
699,400€4.4k-12.5%no data
0.15%
Charles Schwab Investment Management, Inc.
596,555€3.8k0%no data
0.13%
DBS Group Holdings Limited, Asset Management Arm
500,000€3.2k0%no data
0.12%
Marex Spectron Group Limited, Asset Management Arm
458,360€2.9k33.7%0.01%
0.11%
Canaccord Genuity Wealth (International) Ltd.
450,922€2.9k0%no data
0.1%
M. D. Barnard & Co. Ltd., Asset Management Arm
400,000€2.5k0%no data
0.091%
Stifel Asset Management Corp.
357,420€2.3k0%no data
0.075%
Quilter Cheviot Limited
295,742€1.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 04:20
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

N4 Pharma Plc is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Emma UlkerAllenby Capital Limited